ACER

Open: | - |
Change: | - |
Volume: | - |
Low: | - |
High: | - |
High / Low range: | - |
Type: | Stocks |
Ticker: | ACEYY |
ISIN: | TW0002353000 |
ACER news, videos and press releases - Page 5
For more news please use our advanced search feature.
ACER - More news...
ACER - More news...
- 07/08/2020 - 12:43 Acer Reports Consolidated Revenues for June at NT$25.67 Billion, Q2'20 at NT$65.60 Billion - the Highest Over 10 Quarters
- 06/24/2020 - 17:53 The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)
- 06/18/2020 - 08:00 Alfa Romeo Racing ORLEN and Acer Keep Pushing Innovation
- 05/14/2020 - 20:01 Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
- 05/11/2020 - 20:05 Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health
- 05/08/2020 - 07:00 Acer Signs Partnership With Romain Grosjean’s R8G e-Sports Sim Racing Team
- 04/30/2020 - 20:01 Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
- 03/31/2020 - 12:15 Engage from Home: Acer Gains Actionable Insights into Customer Experience with 8x8
- 03/18/2020 - 20:05 Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
- 03/18/2020 - 20:05 Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New Drugs
- 02/28/2020 - 08:00 Acer’s New Predator Monitors Are Set to Make their European Debut
- 02/27/2020 - 15:24 The Predator Intel Extreme Masters Trophy Returns to the of Home of eSports
- 02/26/2020 - 08:00 eSports Platform Planet9 Now Open for Registration at Intel Extreme Masters in Katowice
- 02/25/2020 - 08:00 Play Like the Pros with the Official Predator IEM PCs
- 02/24/2020 - 21:05 Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL®
- 12/16/2019 - 21:05 Acer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders
- 11/13/2019 - 21:05 Acer Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
- 11/06/2019 - 09:37 Acer Reports Q3 2019 Net Income of NT$1.18 Billion and EPS of NT$0.39; Both Mark the Highest in Eight Quarters
- 10/28/2019 - 20:01 Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders
- 08/30/2019 - 17:02 Shareholder Alert: Robbins Arroyo LLP Reminds Investors Acer Therapeutics Inc. (ACER) Sued for Misleading Shareholders
- 08/29/2019 - 16:27 ACER IMMINENT DEADLINE: Rosen, A Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Acer Therapeutics Inc.; Important August 30th Deadline - ACER
- 08/29/2019 - 01:34 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acer Therapeutics (NASDAQ: ACER) and Encourages Acer Investors to Contact the Firm
- 08/28/2019 - 22:46 2-DAY ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Acer Therapeutics, Inc.
- 08/27/2019 - 14:00 FINAL DEADLINE - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 30, 2019
- 08/27/2019 - 12:30 Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference
- 08/13/2019 - 20:05 Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
- 08/01/2019 - 12:30 Acer Therapeutics to Present at the 2019 Webush PacGrow Healthcare Conference
- 07/25/2019 - 12:30 Acer Therapeutics to Host Conference Call and Webcast to Discuss Update on its Pipeline Programs
- 07/17/2019 - 02:05 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACER
- 07/12/2019 - 22:59 Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Acer Therapeutics, Inc. - ACER